Memantine and Donepezil Hydrochlorides Extended-release (Amneal Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Memantine and Donepezil Hydrochlorides Extended-release drug offered from Amneal Pharmaceuticals LLC. This NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amneal Pharmaceuticals LLC |
| NON-PROPRIETARY NAME: | Memantine and Donepezil |
| SUBSTANCE NAME: | MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | NMDA Receptor Antagonists [MoA],N-methyl-D-aspartate Receptor Antagonist [EPC],Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, EXTENDED RELEASE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-02-01 |
| END MARKETING DATE: | 0000-00-00 |
Memantine and Donepezil Hydrochlorides Extended-release HUMAN PRESCRIPTION DRUG Details:
| Item Description | Memantine and Donepezil Hydrochlorides Extended-release from Amneal Pharmaceuticals LLC |
| LABELER NAME: | Amneal Pharmaceuticals LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 28; 10(mg/1; mg/1) |
| START MARKETING DATE: | 2017-02-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 69238-1247_ad61d86b-04dc-4d86-9eee-ce1b453a22b8 |
| PRODUCT NDC: | 69238-1247 |
| APPLICATION NUMBER: | ANDA208328 |
Other MEMANTINE HYDROCHLORIDE; DONEPEZIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
